share_log

Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts

Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts

專家展望: 5位分析師的視角下看cytosorbents
Benzinga ·  10/22 21:00
During the last three months, 5 analysts shared their evaluations of CytoSorbents (NASDAQ:CTSO), revealing diverse outlooks from bullish to bearish.
在過去的三個月中,有5位分析師分享了他們對CytoSorbents (納斯達克:CTSO)的評價,展示了從看好到看淡不同的展望。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖,顯示了過去30天的不同情緒,並將其與前幾個月進行比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $8.2, a high estimate of $10.00, and a low estimate of $1.00. Witnessing a positive shift, the current average has risen by 5.81% from the previous average price target of $7.75.
分析師12個月的目標價格預測揭示了平均目標價爲$8.2,最高估值爲$10.00,最低估值爲$1.00。目前的平均價格已經比之前的目標價格平均值$7.75上漲了5.81%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級:全面解析
The standing of CytoSorbents among financial experts becomes clear...
通過對最近分析師行...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論